Primary, Secondary, and Tertiary Prevention Strategies
The “Middle East Respiratory Syndrome Corona-Virus (MERS-CoV) is a single-stranded RNA novel species of the genus Betacoronavirus” (Al-Tawfiq & Memish, 2014, p. 283). This virus causes a respiratory illness known as Middle East Respiratory Syndrome (MERS). The disease was first reported in 2012 in the Middle East.
The disease causes “various symptoms such as shortness of breath, fever, and coughing” (Al-Tawfiq & Memish, 2014, p. 285). Experts encourage the use of different strategies to deal with MERS. Primary prevention is a powerful approach that can reduce the risks associated with this illness.
This approach has the potential to reduce the possible causes of the disease. Secondary prevention strategies are useful because they control the progression of the targeted disease. Appropriate screening procedures and early interventions can reduce the dangers associated with MERS.
Health professionals should use their skills in order to deal with this condition. Tertiary prevention is effective after the progression of a specific disease. This “kind of prevention involves the treatment and care of an established illness” (Moshi, 2013, p. 19).
The approach minimizes the challenges and negative effects associated with the disease. The strategy also makes it easier for doctors to prevent the complications associated with the targeted disease. Human beings should use these measures in order to deal with MERS. These strategies will ensure the targeted population deals with the dangers associated with MERS.
Strategies for Primary Prevention
Middle East Respiratory Syndrome (MERS) results from zoonotic events or transmissions. Human-to-human transmission is also common for MERS. However, the source and transmission of the MERS virus is not known. That being the case, various primary prevention strategies can be used to control this disease.
The first strategy is avoiding close contact with individuals suffering from different respiratory infections. Human beings should embrace the best hygiene practices. They should also avoid raw fruits, unsafe drinking water, and raw fruits. Health practitioners should encourage more people to avoid contact with suspected wild animals.
Individuals travelling to the Middle East should “seek appropriate medical attention” (Moshi, 2013, p. 21). This practice will make it easier for them to avoid the disease. People should also “avoid raw milk or undercooked camel meat” (Memish, Zumla, & Al-Tawfiq, 2013, p. 980).
This practice is necessary because camels have the potential to transmit the MERS-CoV. Individuals with signs of various respiratory diseases should not travel to other regions. This practice will minimize the chances of transmitting the virus. Some good practices such as hand washing can produce positive results. Individuals should avoid contact with patient suffering from different respiratory diseases.
A proper personal hygiene will also reduce the challenges associated with this disease. Travelers should use the best practices in order to deal with Middle East Respiratory Syndrome (MERS). Every government should introduce adequate screening practices. These practices will deal with MERS (Moshi, 2013).
Secondary Prevention Strategies
These prevention measures focus on the risk factors associated with MERS. Medical practitioners should focus on the best practices in order to alter the development of this disease. This approach is necessary because the disease can produce numerous problems without proper treatment. There is no approved or accurate treatment strategy for this illness.
That being the case, governments should create adequate screening points to monitor the development of this infectious illness. Every suspected case of MERS should be “referred to the right specialists” (Memish et al., 2013, p. 980). This approach will make it easier for more specialists to monitor the development of the disease. The use of supportive strategies will support the health needs of many patients.
Doctors and medical practitioners should use their skills to treat various symptoms associated with this infection. New studies are required in order to understand the risks associated with the Middle East Respiratory Syndrome Corona-Virus (MERS-CoV). Such studies will make it easier for more people to understand how the disease spreads from one person to another (Memish et al., 2013).
Tertiary Prevention Options
The development and transmission of Middle East Respiratory Syndrome is currently unknown. That being the case, the primary and secondary prevention strategies used to control the above disease might be less effective. Tertiary prevention measures should therefore be undertaken after the disease has been established.
Medical practitioners “can use exogenous types IIIIFN and I to reduce the replication of the virus” (Moshi, 2013, p. 13). The “inhibition of viral protease is another effective therapy for treating this disease” (Al-Tawfiq & Memish, 2014, p. 285). The “use of various compounds such as chloroquine, loperamide, interfereon, and lopinavir can also be effective” (Al-Tawfiq & Memish, 2014, p. 286).
Conclusions and Recommendations
Doctors should use appropriate medications in order to reduce the symptoms associated with MER. Some of these symptoms include coughing and breathing difficulties. Every person should use strict measures in order to reduce the spread of this disease.
New studies will identify better treatment methods for Middle East Respiratory Syndrome. New measures should also be identified in order to deal with the problems associated with this disease. The above approaches will present adequate strategies that can deal with this infectious disease.
Al-Tawfiq, J., & Memish, Z. (2014). Middle East Respiratory Syndrome Corona-Virus: Epidemiology and Disease Control Measures. Infection and Drug Resistance, 7(1), 281-287.
Memish, Z., Zumla, A., & Al-Tawfiq, J. (2013). How great is the risk of Middle East Respiratory Syndrome Corona-virus to the Global Population? Expert Review of Anti-infective Therapy, 11(10), 979-981.
Moshi, R. (2013). Middle East Respiratory Syndrome Corona-virus (MERS-CoV): Perceptions, Predictions, Preventions and the Pilgrimage. Clinical Microbiology, 1(1), 12-28.